Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes

Detalles Bibliográficos
Autores principales: Yap, Timothy A., Hamilton, Erika, Bauer, Todd, Dumbrava, Ecaterina E., Jeselsohn, Rinath, Enke, Aaron, Hurley, Sabrina, Lin, Kevin K., Habeck, Jenn, Giordano, Heidi, Shapiro, Geoffrey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865521/
https://www.ncbi.nlm.nih.gov/pubmed/35138920
http://dx.doi.org/10.1200/PO.21.00456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865521/
https://www.ncbi.nlm.nih.gov/pubmed/35138920
http://dx.doi.org/10.1200/PO.21.00456

Ejemplares similares